Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
4.300
-0.050 (-1.15%)
At close: Mar 6, 2026, 4:00 PM EST
4.387
+0.087 (2.02%)
After-hours: Mar 6, 2026, 7:24 PM EST
Bolt Biotherapeutics Stock Forecast
BOLT's stock price has decreased by -51.69% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Bolt Biotherapeutics stock have an average target of 34, with a low estimate of 7.00 and a high estimate of 75. The average target predicts an increase of 690.70% from the current stock price of 4.30.
Analyst Consensus: Buy
* Price targets were last updated on Oct 20, 2025.
Analyst Ratings
The average analyst rating for Bolt Biotherapeutics stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +62.79% | Oct 20, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $4 → $75 | Strong Buy | Maintains | $4 → $75 | +1,644.19% | Aug 15, 2025 |
| Lake Street | Lake Street | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +1,760.47% | May 20, 2025 |
| Stifel | Stifel | Hold Maintains $25 → $20 | Hold | Maintains | $25 → $20 | +365.12% | May 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 25, 2025 |
Financial Forecast
Revenue This Year
5.23M
from 7.69M
Decreased by -31.94%
Revenue Next Year
2.38M
from 5.23M
Decreased by -54.53%
EPS This Year
-21.65
from -33.06
EPS Next Year
-19.87
from -21.65
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 7.0M | 6.3M | ||||
| Avg | 5.2M | 2.4M | ||||
| Low | 2.9M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -8.6% | 20.4% | ||||
| Avg | -31.9% | -54.5% | ||||
| Low | -61.8% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -19.72 | -12.63 | ||||
| Avg | -21.65 | -19.87 | ||||
| Low | -23.20 | -32.76 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.